Italian pharma major Recordati presented four poster presentations and one product theater featuring the company’s endocrinology portfolio at the Endocrine Society’s annual meeting, ENDO 2025, taking ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

NYCFC Head Coach Nick Cushing analyzes the comeback win against New England. He discusses team performance, key plays, and ...

Ben Askren gave an update on his health a month after the MMA fighter was hospitalized with a severe case of pneumonia, ...

Sterotherapeutics LLC, a clinical-stage biopharmaceutical company focused on rare endocrine diseases, today announced that the first patient has been successfully dosed in its ongoing ...

Patients with Cushing's disease treated with bilateral adrenalectomy are also at risk for Nelson's syndrome (corticotroph tumor progression) which occurs in up to 50% of the patients. [1, 11, 19 ...

The long-term safety and efficacy of osilodrostat in patients with endogenous Cushing syndrome was evaluated in a real-world setting in the LINC6 trial (ClinicalTrials.gov Identifier: NCT05382156).

RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME ISTURISA® is a cortisol synthesis ...

RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME ISTURISA® is a cortisol synthesis ...

Cushing's syndrome can often have a devastating impact on the lives of patients and their families. Elevated cortisol levels in Cushing's syndrome, if not properly controlled, can be associated with ...

If cortisol stays elevated consistently, the blood-sugar spike it sets off can lead to weight gain around the midsection. It can also keep you up at night; people with persistently higher cortisol ...

The FDA has filed the NDA submission for relacorilant to treat patients with Cushing syndrome (hypercortisolism).